Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Randomized, Parallel, Placebo-active Controlled, Multi-center Phase II Clinical Trial to Investigate the Efficacy and Safety of YH14642 Following 12-week Oral Administration in Patients With Chronic Periodontal Disease
Brief Summary: This study is designed to evaluate the efficacy and the safety of YH14642 in Korea patients with chronic periodontitis, in order to investigate the recommended therapeutic dose.


Options:
A: Arm Label: Moxifloxacin; Type: EXPERIMENTAL; Interventions: Drug: moxifloxacin | Arm Label: Ciprofloxacin plus metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ciprofloxacin plus metronidazole | Intervention Type: DRUG; Name: moxifloxacin; Assigned to Arm(s): Moxifloxacin | Intervention Type: DRUG; Name: Ciprofloxacin plus metronidazole; Assigned to Arm(s): Ciprofloxacin plus metronidazole
B: Arm Label: Periodontal intervention, sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Metronidazol | Intervention Type: DRUG; Name: Metronidazol; Assigned to Arm(s): Periodontal intervention, sugar pill
C: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Scaling and root planing, Drug: Placebos active phase, Drug: Placebos healing phase | Arm Label: Active phase; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing, Drug: Metronidazole active phase, Drug: Amoxicillin active phase, Drug: Placebos healing phase | Arm Label: Healing phase; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing, Drug: Metronidazole healing phase, Drug: Amoxicillin healing phase, Drug: Placebos active phase | Intervention Type: PROCEDURE; Name: Scaling and root planing; Assigned to Arm(s): Active phase, Control, Healing phase | Intervention Type: DRUG; Name: Metronidazole active phase; Assigned to Arm(s): Active phase | Intervention Type: DRUG; Name: Metronidazole healing phase; Assigned to Arm(s): Healing phase | Intervention Type: DRUG; Name: Amoxicillin active phase; Assigned to Arm(s): Active phase | Intervention Type: DRUG; Name: Amoxicillin healing phase; Assigned to Arm(s): Healing phase | Intervention Type: DRUG; Name: Placebos active phase; Assigned to Arm(s): Control, Healing phase | Intervention Type: DRUG; Name: Placebos healing phase; Assigned to Arm(s): Active phase, Control
D: Arm Label: YH14642 A-I; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-II; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-III; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: Active Comparator B; Type: ACTIVE_COMPARATOR; Interventions: Drug: INSADOL[Zea mays L. extract] 35mg Tab | Arm Label: Active Comparator C; Type: ACTIVE_COMPARATOR; Interventions: Drug: DENTISTA[Doxycycline hyclate] 20mg Cap | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-I | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-II | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-III | Intervention Type: DRUG; Name: INSADOL[Zea mays L. extract] 35mg Tab; Assigned to Arm(s): Active Comparator B | Intervention Type: DRUG; Name: DENTISTA[Doxycycline hyclate] 20mg Cap; Assigned to Arm(s): Active Comparator C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D